Search results for " Vaccines"

showing 10 items of 472 documents

“MIATA”—Minimal Information about T Cell Assays

2009

Immunotherapy, especially therapeutic vaccination, has a great deal of potential in the treatment of cancer and certain infectious diseases such as HIV (Allison et al., 2006; Fauci et al., 2008; Feldmann and Steinman, 2005). Numerous vaccine candidates have been tested in patients with a variety of tumor types and chronic viral diseases. Often, the best way to assess the clinical potential of these vaccines is to monitor the induced T cell response, and yet there are currently no standards for reporting these results. This letter is an effort to address this problem.

T-LymphocytesT cellmedicine.medical_treatmentImmunologyHuman immunodeficiency virus (HIV)medicine.disease_causeT cell responseCancer VaccinesArticleMonitoring ImmunologicNeoplasmsmedicineHumansImmunology and AllergyIn patientImmunoassaybusiness.industryViral VaccineCancerViral VaccinesImmunotherapymedicine.diseaseVaccinationInfectious Diseasesmedicine.anatomical_structureVirus DiseasesPractice Guidelines as TopicImmunologyImmunotherapybusinessCancer Vaccines/immunology; Cancer Vaccines/therapeutic use; Humans; Immunoassay/standards; Immunotherapy; Monitoring Immunologic/standards; Neoplasms/therapy; Practice Guidelines as Topic/standards; T-Lymphocytes/immunology; Viral Vaccines/immunology; Viral Vaccines/therapeutic use; Virus Diseases/therapyImmunity
researchProduct

Editorial: Activation, functions, and generation of immunological memory in γδ T lymphocytes: lessons from nonhuman primates

2014

T cells constitute an unconventional lymphocyte population with distinct functions complementary to those of CD4 and CD8 T cells. As such, they have both adaptive features, such as expression of the TCR, and innate-like functions reminiscent of NK cells, with whom they share extensive repertoires of activating and inhibitory receptors [1, 2]. Although most antigens recognized by murine T cells remain obscure, advances have been made in identifying ligands for human T cells. The majority of circulating human T lymphocytes expresses a TCR formed by the preferentially-paired V 9 and V 2 chains (here and thereafter, called V 9V 2 T cells). Instead of binding peptides associated with molecules b…

TRAIL.T cellLymphocyteImmunologyPopulationMajor histocompatibility complexAntigenT-Lymphocyte SubsetsmedicineAnimalsImmunology and AllergyCytotoxic T cellListeriosiseducationLungAntigens Bacterialeducation.field_of_studyTumorbiologyEffectorT-cell receptorCell Biologygamma delta cellListeria monocytogenesOrganophosphatesCell biologymedicine.anatomical_structureBacterial VaccinesImmunologybiology.proteinSpotlight on Leading Edge ResearchImmunizationImmunologic MemoryJournal of Leukocyte Biology
researchProduct

Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra®

2021

None

Technology Assessment BiomedicalBiomedicalVaccinationInfluenzaChild; Humans; Italy; Technology Assessment Biomedical; Vaccination; Influenza Vaccines; Influenza HumanItalyInfluenza VaccinesTechnology AssessmentInfluenza HumanNoneHumansChildSettore MED/42 - IGIENE GENERALE E APPLICATAHuman
researchProduct

A mid-term estimate of 2018/2019 vaccine effectiveness to prevent laboratory confirmed A(H1N1)pdm09 and A(H3N2) influenza cases in Sicily (Italy)

2019

Abstract Influenza season started in Italy during the month of October 2018, approaching the epidemic peak in January 2019. This report aim to explore the mid-term virologic surveillance data of the 2018–2019 influenza season in Sicily and to estimate the effectiveness of seasonal influenza vaccine (VE) against A(H1N1)pdm09 and A(H3N2) influenza viruses. A test-negative design was used to evaluate influenza VE. In Sicily, almost all influenza infections were sustained by influenza type A viruses, of which 62.3% were A(H3N2) and 36.3% A(H1N1)pdm09. A reduction of laboratory confirmed influenza cases in Sicilian population immunized against influenza were observed. In particular, an overall s…

Test-negative designAdultMaleVeterinary medicineSurveillance dataAdolescent030231 tropical medicinePopulationInfluenza seasonSurveillance networkSeasonal influenzaYoung Adult03 medical and health sciencesInfluenza A Virus H1N1 Subtype0302 clinical medicineInfluenza vaccine effectiveneInfluenza HumanHumansMedicine030212 general & internal medicineChildeducationSicilyVaccine PotencyAgededucation.field_of_studyGeneral VeterinaryGeneral Immunology and Microbiologybusiness.industryInfluenza A Virus H3N2 SubtypeInfluenza epidemicVaccinationPublic Health Environmental and Occupational HealthInfantvirus diseasesInfluenza aLaboratory confirmed caseMiddle AgedA h1n1 pdm09Infectious DiseasesInfluenza viruseInfluenza VaccinesCase-Control StudiesChild PreschoolMolecular MedicineFemaleImmunizationbusinessVaccine
researchProduct

Synthesis of tumor-associated glycopeptide antigens for the development of tumor-selective vaccines

2004

In contrast to normal cells, the glycoprotein profile on epithelial tumor cells is distinctly altered. Due to an incomplete formation of the glycan side-chains resulting from a premature sialylation, additional peptide epitopes become accessible to the immune system in mucin-type glycoproteins on tumor cells. These tumor-associated structure alterations constitute the basis for a selective immunological attack on cancer cells. For the construction of immunostimulating antigens, glycopeptide partial structures from the mucins MUC1 and MUC4 carrying the tumor-associated sialyl-T(N), alpha2,6-sialyl-T and alpha2,3-sialyl-T antigens have been synthesized. Employing different linkers such as the…

ThreonineGlycanGeneral Chemical EngineeringT cellAsialoglycoproteinsOligosaccharidesCancer VaccinesBiochemistryEpitopeImmune systemAntigenMaterials ChemistrymedicineHumansCytotoxic T cellAntigens Tumor-Associated CarbohydrateNeoplasms Glandular and EpithelialMUC1biologyChemistryGlycopeptidesMucinsGeneral MedicineGeneral ChemistryGlycopeptidecarbohydrates (lipids)medicine.anatomical_structureBiochemistrySialic Acidsbiology.proteinImmunizationThe Chemical Record
researchProduct

Biomimetic synthesis of the tumor-associated (2,3)-sialyl-T antigen and its incorporation into glycopeptide antigens from the mucins MUC1 and MUC4.

2004

Glycoproteins on epithelial tumor cells often exhibit aberrant glycosylation profiles. The incomplete formation of the glycan side chains resulting from a down-regulated glucosamine transfer and a premature sialylation results in additional peptide epitopes, which become accessible to the immune system in mucin-type glycoproteins. These cancer-specific structure alterations are considered to be a promising basis for selective immunological attack on tumor cells. Among the tumor-associated saccharide antigens, the (2,3)-sialyl-T antigen has been identified as the most abundant glycan, found in several different carcinoma cell lines. According to a linear biomimetic strategy, the (2,3)-sialyl…

ThreonineGlycanMagnetic Resonance SpectroscopyMolecular Sequence DataCancer VaccinesCatalysisEpitopeMass SpectrometryImmune systemAntigenAntigens NeoplasmBiomimeticsMUC1Chromatography High Pressure LiquidGlycoproteinschemistry.chemical_classificationbiologyMucin-4Organic ChemistryMucinMucin-1GlycopeptidesMucinsGeneral ChemistryGlycopeptidecarbohydrates (lipids)chemistryBiochemistryCarbohydrate SequenceTandem Repeat Sequencesbiology.proteinIndicators and ReagentsGlycoproteinChemistry (Weinheim an der Bergstrasse, Germany)
researchProduct

Transcriptional targeting of dendritic cells in gene gun-mediated DNA immunization favors the induction of type 1 immune responses

2003

Cutaneous dendritic cells (DC) are pivotal for the elicitation of antigen-specific immune responses following gene gun-mediated biolistic transfection of the skin. We transcriptionally targeted transgene expression to DC using vectors containing the murine fascin promoter (pFascin) to control antigen production and compared the immune response elicited with conventional DNA immunization using plasmid constructs with the ubiquitously active CMV promoter (pCMV). Biolistic transfection with pFascin initiated a marked type 1 immune response characterized by the occurrence of a large population of IFN-gamma-producing T helper (Th) cells in spleen and draining lymph nodes. Consistently, immunoglo…

Transcription GeneticGenetic VectorsCancer VaccinesDNA vaccinationGene gunImmune systemAntigenGenes ReporterNeoplasmsDrug DiscoveryGeneticsCytotoxic T cellMolecular BiologyPharmacologybiologyDendritic CellsTransfectionBiolisticsTh1 CellsIsotypeMolecular biologybiology.proteinMolecular MedicineAntibodyCell DivisionSpleenPlasmidsMolecular Therapy
researchProduct

A Trans-amplifying RNA Vaccine Strategy for Induction of Potent Protective Immunity

2019

Here, we present a potent RNA vaccine approach based on a novel bipartite vector system using trans-amplifying RNA (taRNA). The vector cassette encoding the vaccine antigen originates from an alphaviral self-amplifying RNA (saRNA), from which the replicase was deleted to form a transreplicon. Replicase activity is provided in trans by a second molecule, either by a standard saRNA or an optimized non-replicating mRNA (nrRNA). The latter delivered 10- to 100-fold higher transreplicon expression than the former. Moreover, expression driven by the nrRNA-encoded replicase in the taRNA system was as efficient as in a conventional monopartite saRNA system. We show that the superiority of nrRNA- ov…

Translational efficiencyGenetic VectorsRNA-dependent RNA polymeraseHemagglutinin (influenza)Hemagglutinin Glycoproteins Influenza VirusBiologyAntibodies ViralMadin Darby Canine Kidney CellsMice03 medical and health sciencesDogsImmunogenicity VaccineInfluenza A Virus H1N1 Subtype0302 clinical medicineOrthomyxoviridae InfectionsCricetinaeInfluenza HumanDrug DiscoveryGeneticsAnimalsHumansViral Replicase Complex ProteinsRepliconMolecular BiologyGene030304 developmental biologyPharmacologyMice Inbred BALB C0303 health sciencesMessenger RNAVaccinationRNATranslation (biology)Antibodies NeutralizingSemliki forest virusVirologyHEK293 CellsInfluenza Vaccines030220 oncology & carcinogenesisbiology.proteinRNA ViralMolecular MedicineFemaleOriginal ArticleMolecular Therapy
researchProduct

Estudios epidemiológicos y virológicos sobre la poliomielitis en Valencia (1959-1969) = Epidemiological and virological studies into the poliomyeliti…

2009

Los estudios sobre el virus de la polio comenzaron en Valencia en 1959 de la mano del microbiólogo Vicente Sanchis-Bayarri Vaillant. Tras su formación en virología en la Universidad de Rochester y en el Instituto Pasteur, puso en marcha un laboratorio de cultivos celulares en la Facultad de Medicina de Valencia, en donde desarrolló una técnica diagnóstica nueva para el virus de la polio. Por otra parte, se llevaron a cabo estudios epidemiológicos antes y después de la campaña de vacunación de 1963, que demostraron la eficacia de la vacuna oral de Sabin y su inocuidad.// Els estudis sobre el virus de la pòlio van començar a València en 1959 de la mà del microbiòleg Vicente Sanchis-Bayarri Va…

UNESCO::CIENCIAS DE LA VIDA::Inmunología ::Vacunaspoliovirus:CIENCIAS DE LA VIDA::Inmunología ::Vacunas [UNESCO]poliomielitisvacunes de la polio:CIENCIAS DE LA VIDA::Virología [UNESCO]vaccination campaigns:CIENCIAS MÉDICAS ::Epidemiología [UNESCO]polio virusUNESCO::CIENCIAS DE LA VIDA::VirologíaUNESCO::HISTORIA::Historia por especialidades::Historia de la medicinaUNESCO::CIENCIAS MÉDICAS ::Epidemiologíaepidemiology:HISTORIA::Historia por especialidades::Historia de la medicina [UNESCO]campanyes de vacunacióepidemiologiacampañas de vacunaciónpolio vaccinespoliomyelitisvacunas de la polioepidemiología
researchProduct

Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells.

2006

AbstractAdoptive transfer of dendritic cells (DCs) transfected with in vitro–transcribed, RNA-encoding, tumor-associated antigens has recently entered clinical testing as a promising approach for cancer immunotherapy. However, pharmacokinetic exploration of RNA as a potential drug compound and a key aspect of clinical development is still pending. While investigating the impact of different structural modifications of RNA molecules on the kinetics of the encoded protein in DCs, we identified components located 3′ of the coding region that contributed to a higher transcript stability and translational efficiency. With the use of quantitative reverse transcription–polymerase chain reaction (R…

Untranslated regionCD4-Positive T-LymphocytesMaleTranslational efficiencyT cellRNA StabilityImmunologyAntigen presentationBiologyCD8-Positive T-LymphocytesLymphocyte ActivationTransfectionBiochemistryCancer VaccinesImmunotherapy AdoptiveMiceAntigens NeoplasmNeoplasmsmedicineCoding regionAnimalsHumansRNA NeoplasmAntigen-presenting cellCells CulturedAntigen PresentationRNACell BiologyHematologyDendritic cellDendritic CellsVirologyCoculture TechniquesCell biologymedicine.anatomical_structurePoly ABlood
researchProduct